Drugs affecting the gastrointestinal system

(R)-ethyl 2-(pyrrolidin-3-yl)acetate hydrochloride.

(R)-ethyl 2-(pyrrolidin-3-yl)acetate hydrochloride.

(R)-Ethyl 3-methylpiperidine-3-carboxylate.

(R)-Ethyl 3-methylpiperidine-3-carboxylate.

(R)-Ethyl 3-methylpiperidine-3-carboxylate.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.

(R)-Fmoc-4-(3-pyridyl)-β-Homoala-OH.

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1 -selective inhibitor, with an IC 50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation,